يعرض 1 - 10 نتائج من 79 نتيجة بحث عن '"Th17 Cell"', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
    رسالة جامعية
  2. 2
    رسالة جامعية
  3. 3
  4. 4
  5. 5
    مورد إلكتروني
  6. 6
    مورد إلكتروني

    URL: http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-324583Test
    2021, 3:9, s. 642-653
    ACR Open Rheumatology, 2578-5745, 2021, 3:9, s. 642-653

  7. 7
    مورد إلكتروني

    مصطلحات الفهرس: disease association, disease severity, down regulation, encephalitis/co [Complication], encephalitis/dt [Drug Therapy], encephalitis/pc [Prevention], endothelium cell, functional status, hormone release, human, immune deficiency, immunoreactivity, immunosuppressive treatment, innate immunity, intracellular signaling, lymphocytopenia/co [Complication], mechanical thrombectomy, microglia, neuroimaging, neuroprotection, neutrophil lymphocyte ratio, nonhuman, priority journal, protein expression, regulatory T lymphocyte, review, Th1 cell, Th17 cell, Th2 cell, upregulation, 1 (2 bromophenyl) 3 (2 hydroxy 4 nitrophenyl)urea/dt [Drug Therapy], alteplase/dt [Drug Therapy], apocynin/dt [Drug Therapy], beta 2 adrenergic receptor/ec [Endogenous Compound], CD14 antigen/ec [Endogenous Compound], CD16 antigen/ec [Endogenous Compound], chemokine receptor CCR2/ec [Endogenous Compound], colony stimulating factor 1/ec [Endogenous Compound], colony stimulating factor receptor/ec [Endogenous Compound], corticotropin/ec [Endogenous Compound], corticotropin releasing factor/ec [Endogenous Compound], CXCL1 chemokine/ec [Endogenous Compound], CXCL2 chemokine/ec [Endogenous Compound], disufenton sodium/dt [Drug Therapy], endothelial leukocyte adhesion molecule 1/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], heat shock protein/ec [Endogenous Compound], high mobility group B1 protein/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], intercellular adhesion molecule 1/ec [Endogenous Compound], interleukin 1 receptor like 1 protein/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 33/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], matrix metalloproteinase/ec [Endogenous Compound], mifepristone/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], PADGEM protein/ec [Endogenous Compound], pattern recognition receptor/ec [Endogenous Compound], propranolol/dt [Drug Therapy], protein kinase C delta/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], tenecteplase/dt [Drug Therapy], toll like receptor/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, uridine triphosphate/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], stent retriever, colony stimulating factor 1 receptor/ec [Endogenous Compound], toll like receptor 13/ec [Endogenous Compound], immunocompetent cell, adaptive immunity, antigen expression, apoptosis, blood brain barrier, brain blood flow, brain infarction size, brain ischemia/dt [Drug Therapy], brain ischemia/su [Surgery], catecholamine release, cell activation, cell infiltration, cell interaction, cellular immunity, complement activation, cytokine release, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27422Test
    Trends in Pharmacological Sciences
    Click here for full text options
    LibKey Link

  8. 8
    مورد إلكتروني

    مصطلحات الفهرس: disease association, disease severity, down regulation, encephalitis/co [Complication], encephalitis/dt [Drug Therapy], encephalitis/pc [Prevention], endothelium cell, functional status, hormone release, human, immune deficiency, immunoreactivity, immunosuppressive treatment, innate immunity, intracellular signaling, lymphocytopenia/co [Complication], mechanical thrombectomy, microglia, neuroimaging, neuroprotection, neutrophil lymphocyte ratio, nonhuman, priority journal, protein expression, regulatory T lymphocyte, review, Th1 cell, Th17 cell, Th2 cell, upregulation, 1 (2 bromophenyl) 3 (2 hydroxy 4 nitrophenyl)urea/dt [Drug Therapy], alteplase/dt [Drug Therapy], apocynin/dt [Drug Therapy], beta 2 adrenergic receptor/ec [Endogenous Compound], CD14 antigen/ec [Endogenous Compound], CD16 antigen/ec [Endogenous Compound], chemokine receptor CCR2/ec [Endogenous Compound], colony stimulating factor 1/ec [Endogenous Compound], colony stimulating factor receptor/ec [Endogenous Compound], corticotropin/ec [Endogenous Compound], corticotropin releasing factor/ec [Endogenous Compound], CXCL1 chemokine/ec [Endogenous Compound], CXCL2 chemokine/ec [Endogenous Compound], disufenton sodium/dt [Drug Therapy], endothelial leukocyte adhesion molecule 1/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], heat shock protein/ec [Endogenous Compound], high mobility group B1 protein/ec [Endogenous Compound], immunoglobulin enhancer binding protein/ec [Endogenous Compound], intercellular adhesion molecule 1/ec [Endogenous Compound], interleukin 1 receptor like 1 protein/ec [Endogenous Compound], interleukin 10/ec [Endogenous Compound], interleukin 17/ec [Endogenous Compound], interleukin 18/ec [Endogenous Compound], interleukin 1beta/ec [Endogenous Compound], interleukin 33/ec [Endogenous Compound], interleukin 37/ec [Endogenous Compound], interleukin 4/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], matrix metalloproteinase/ec [Endogenous Compound], mifepristone/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], PADGEM protein/ec [Endogenous Compound], pattern recognition receptor/ec [Endogenous Compound], propranolol/dt [Drug Therapy], protein kinase C delta/ec [Endogenous Compound], reactive oxygen metabolite/ec [Endogenous Compound], tenecteplase/dt [Drug Therapy], toll like receptor/ec [Endogenous Compound], toll like receptor 1/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, uridine triphosphate/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], stent retriever, colony stimulating factor 1 receptor/ec [Endogenous Compound], toll like receptor 13/ec [Endogenous Compound], immunocompetent cell, adaptive immunity, antigen expression, apoptosis, blood brain barrier, brain blood flow, brain infarction size, brain ischemia/dt [Drug Therapy], brain ischemia/su [Surgery], catecholamine release, cell activation, cell infiltration, cell interaction, cellular immunity, complement activation, cytokine release, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27422Test
    Trends in Pharmacological Sciences
    LibKey Link

  9. 9
    مورد إلكتروني
  10. 10